{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T20:04:01Z","timestamp":1780085041086,"version":"3.54.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004442","name":"Narodowym Centrum Nauki","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004442","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004281","name":"National Science Centre Poland","doi-asserted-by":"publisher","award":["2023\/07\/X\/NZ4\/00338"],"award-info":[{"award-number":["2023\/07\/X\/NZ4\/00338"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.micpath.2025.107872","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T12:22:30Z","timestamp":1751545350000},"page":"107872","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Stimulating effect of lactoferrin on antibacterial efficacy of vB_SauM-A phage against multi-drug resistant strains of Staphylococcus aureus"],"prefix":"10.1016","volume":"207","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-0141-1749","authenticated-orcid":false,"given":"Milena","family":"Grzenkowicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Ka\u017amierczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9222-7330","authenticated-orcid":false,"given":"Lidia","family":"Piechowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5023-1531","authenticated-orcid":false,"given":"Katarzyna","family":"Kosznik-Kwa\u015bnicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2025.107872_bib1","series-title":"Advances in Virus Research","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/B978-0-12-394438-2.00001-3","article-title":"Chapter 1 - phage therapy\u2014history from twort and D'Herelle through Soviet experience to current approaches","volume":"vol. 83","author":"Chanishvili","year":"2012"},{"key":"10.1016\/j.micpath.2025.107872_bib2","doi-asserted-by":"crossref","first-page":"130","DOI":"10.4161\/bact.20757","article-title":"The strange history of phage therapy","volume":"2","author":"Summers","year":"2012","journal-title":"Bacteriophage"},{"key":"10.1016\/j.micpath.2025.107872_bib3","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1080\/14712598.2019.1651287","article-title":"The fall and rise of phage therapy in modern medicine","volume":"19","author":"G\u00f3rski","year":"2019","journal-title":"Expet Opin. Biol. Ther."},{"key":"10.1016\/j.micpath.2025.107872_bib4","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1016\/S0140-6736(05)66759-1","article-title":"Georgia: an unlikely stronghold for bacteriophage therapy","volume":"365","author":"Parfitt","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.micpath.2025.107872_bib5","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.3390\/v14061170","article-title":"A thorough synthesis of phage therapy unit activity in poland\u2014its history, milestones and international recognition","volume":"14","author":"\u017baczek","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.micpath.2025.107872_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.654038","article-title":"Efficacy of Phage- and bacteriocin-based therapies in combatting nosocomial MRSA infections","volume":"8","author":"Walsh","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.micpath.2025.107872_bib7","article-title":"Potential of therapeutic bacteriophages in nosocomial infection management","volume":"12","author":"Wu","year":"2021","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2025.107872_bib8","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3390\/v13010060","article-title":"A case of phage therapy against pandrug-resistant Achromobacter xylosoxidans in a 12-Year-Old lung-transplanted cystic fibrosis patient","volume":"13","author":"Lebeaux","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.micpath.2025.107872_bib9","article-title":"Progress and pitfalls of bacteriophage therapy in critical care: a concise definitive review","volume":"3","author":"Valente","year":"2021","journal-title":"Crit. Care Explor"},{"key":"10.1016\/j.micpath.2025.107872_bib10","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/s41564-024-01705-x","article-title":"Personalized bacteriophage therapy outcomes for 100 consecutive cases: a multicentre, multinational, retrospective observational study","volume":"9","author":"Pirnay","year":"2024","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.micpath.2025.107872_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1199657","article-title":"Case report: analysis of phage therapy failure in a patient with a Pseudomonas aeruginosa prosthetic vascular graft infection","volume":"10","author":"Blasco","year":"2023","journal-title":"Front. Med."},{"key":"10.1016\/j.micpath.2025.107872_bib12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4161\/bact.1.2.14590","article-title":"Pros and cons of phage therapy","volume":"1","author":"Loc-Carrillo","year":"2011","journal-title":"Bacteriophage"},{"key":"10.1016\/j.micpath.2025.107872_bib13","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.3390\/molecules27061857","article-title":"Limitations of phage therapy and corresponding optimization strategies: a review","volume":"27","author":"Lin","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.micpath.2025.107872_bib14","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nrmicro2315","article-title":"Bacteriophage resistance mechanisms","volume":"8","author":"Labrie","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.micpath.2025.107872_bib15","doi-asserted-by":"crossref","DOI":"10.1099\/mic.0.001110","article-title":"Functional diversity increases the efficacy of phage combinations","volume":"167","author":"Wright","year":"2021","journal-title":"Microbiology"},{"key":"10.1016\/j.micpath.2025.107872_bib16","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1021\/acsinfecdis.1c00117","article-title":"Synergistic effects of phage\u2013antibiotic combinations against Citrobacter amalonaticus","volume":"8","author":"Manohar","year":"2022","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.micpath.2025.107872_bib17","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0161-5890(03)00152-4","article-title":"Lactoferrin\u2014A multifunctional protein with antimicrobial properties","volume":"40","author":"Farnaud","year":"2003","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.micpath.2025.107872_bib18","first-page":"189","article-title":"The antimicrobial activity of lactoferrin: current status and perspectives","volume":"17","author":"Orsi","year":"2004","journal-title":"Biometals Int. J. Role Met. Ions Biol. Biochem. Med."},{"key":"10.1016\/j.micpath.2025.107872_bib19","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1742-481X.2011.00781.x","article-title":"Anti-biofilm efficacy of a lactoferrin\/xylitol wound hydrogel used in combination with silver wound dressings","volume":"8","author":"Ammons","year":"2011","journal-title":"Int. Wound J."},{"key":"10.1016\/j.micpath.2025.107872_bib20","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1080\/08927014.2013.773317","article-title":"Mini-review: lactoferrin: a bioinspired, anti-biofilm therapeutic","volume":"29","author":"Ammons","year":"2013","journal-title":"Biofouling"},{"key":"10.1016\/j.micpath.2025.107872_bib21","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1021\/acsinfecdis.1c00087","article-title":"Analysis of antimicrobial and antibiofilm activity of human milk lactoferrin compared to bovine lactoferrin against multidrug resistant and susceptible Acinetobacter baumannii clinical isolates","volume":"7","author":"Avery","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.micpath.2025.107872_bib22","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.3390\/antibiotics11091256","article-title":"Activity of phage\u2013lactoferrin mixture against multi drug resistant Staphylococcus aureus biofilms","volume":"11","author":"Kosznik-Kwa\u015bnicka","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.micpath.2025.107872_bib23","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3390\/microorganisms7100471","article-title":"Characterization of the three new kayviruses and their lytic activity against multidrug-resistant Staphylococcus aureus","volume":"7","author":"\u0141ubowska","year":"2019","journal-title":"Microorganisms"},{"key":"10.1016\/j.micpath.2025.107872_bib24","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1089\/mdr.2020.0399","article-title":"Biofilm formation and prevalence of biofilm-related genes among clinical strains of multidrug-resistant Staphylococcus aureus","volume":"27","author":"Ka\u017amierczak","year":"2021","journal-title":"Microb. Drug Resist."},{"key":"10.1016\/j.micpath.2025.107872_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/srep34338","article-title":"Biodiversity of bacteriophages: morphological and biological properties of a large group of phages isolated from urban sewage","volume":"6","author":"Jurczak-Kurek","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2025.107872_bib26","series-title":"Detection and Enumeration of Bacteria, Yeast, Viruses, and Protozoan in Foods and Freshwater","first-page":"157","article-title":"Double-layer plaque assay technique for enumeration of virus surrogates","author":"da Silva","year":"2021"},{"key":"10.1016\/j.micpath.2025.107872_bib27","doi-asserted-by":"crossref","first-page":"6152","DOI":"10.3390\/ijms21176152","article-title":"Characteristics of a series of three bacteriophages infecting Salmonella enterica strains","volume":"21","author":"Kosznik-Kwa\u015bnicka","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micpath.2025.107872_bib28","series-title":"Bacteriophages: Methods and Protocols, Volume 1: Isolation, Characterization, and Interactions","first-page":"175","article-title":"Practical methods for determining phage growth parameters","author":"Hyman","year":"2009"},{"key":"10.1016\/j.micpath.2025.107872_bib29","doi-asserted-by":"crossref","first-page":"208","DOI":"10.2340\/00015555-3466","article-title":"Skin infections caused by Staphylococcus aureus","volume":"100","author":"Giudice","year":"2020","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.micpath.2025.107872_bib30","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3390\/antibiotics12020286","article-title":"Phage therapy as an alternative treatment modality for resistant Staphylococcus aureus infections","volume":"12","author":"Atshan","year":"2023","journal-title":"Antibiotics"},{"key":"10.1016\/j.micpath.2025.107872_bib31","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.medcli.2023.01.012","article-title":"Staphylococcus aureus bacteremia in patients with SARS-CoV-2 infection","volume":"160","author":"Falces-Romero","year":"2023","journal-title":"Med. Clin. Engl. Ed"},{"key":"10.1016\/j.micpath.2025.107872_bib32","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/S0924-8579(09)70544-8","article-title":"Why is community-associated MRSA spreading across the world and how will it change clinical practice?","volume":"34","author":"Bassetti","year":"2009","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.micpath.2025.107872_bib33","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ijantimicag.2011.09.030","article-title":"Meticillin-resistant Staphylococcus Aureus (MRSA): global epidemiology and harmonisation of typing methods","volume":"39","author":"Stefani","year":"2012","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.micpath.2025.107872_bib34","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13756-020-00785-8","article-title":"Nasal carriage of methicillin-resistant Staphylococcus aureus (MRSA) among undocumented migrants and uninsured legal residents in amsterdam, the Netherlands: a cross-sectional study","volume":"9","author":"van Dulm","year":"2020","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"10.1016\/j.micpath.2025.107872_bib35","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s00284-015-0968-6","article-title":"Combined application of essential oil compounds and bacteriophage to inhibit growth of Staphylococcus aureus in vitro","volume":"72","author":"Ghosh","year":"2016","journal-title":"Curr. Microbiol."},{"key":"10.1016\/j.micpath.2025.107872_bib36","doi-asserted-by":"crossref","first-page":"839","DOI":"10.3390\/antibiotics11070839","article-title":"Benefits of combined phage\u2013antibiotic therapy for the control of antibiotic-resistant bacteria: a literature review","volume":"11","author":"Diallo","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.micpath.2025.107872_bib37","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3390\/pharmaceutics15010072","article-title":"Antimicrobial proteins: structure, molecular action, and therapeutic potential","volume":"15","author":"Hassan","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.micpath.2025.107872_bib38","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.3168\/jds.2006-598","article-title":"Efficacy of a lactoferrin-penicillin combination to treat \u03b2-Lactam-Resistant Staphylococcus aureus mastitis","volume":"90","author":"Petitclerc","year":"2007","journal-title":"J. Dairy Sci."},{"key":"10.1016\/j.micpath.2025.107872_bib39","doi-asserted-by":"crossref","first-page":"66","DOI":"10.2527\/jas.2007-0216","article-title":"Utilization of lactoferrin to fight antibiotic-resistant mammary gland Pathogens1,2","volume":"86","author":"Lacasse","year":"2008","journal-title":"J. Anim. Sci."},{"key":"10.1016\/j.micpath.2025.107872_bib40","first-page":"42","article-title":"The concerted action of lactoferrin and bacteriophages in the clearance of bacteria in sublethally infected mice","volume":"62","author":"Zimecki","year":"2008","journal-title":"Postepy Hig. Med. Doswiadczalnej Online"},{"key":"10.1016\/j.micpath.2025.107872_bib41","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1365-2672.2010.04863.x","article-title":"In vitro lung delivery of bacteriophages KS4-M and \u03a6KZ using dry powder inhalers for treatment of Burkholderia cepacia complex and Pseudomonas aeruginosa infections in cystic fibrosis","volume":"110","author":"Golshahi","year":"2011","journal-title":"J. Appl. Microbiol."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401025005972?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401025005972?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T21:13:16Z","timestamp":1760562796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401025005972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":41,"alternative-id":["S0882401025005972"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2025.107872","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stimulating effect of lactoferrin on antibacterial efficacy of vB_SauM-A phage against multi-drug resistant strains of Staphylococcus aureus","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2025.107872","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107872"}}